January-06 2009
January-06 2009
Stock Futures Regain Momentum Ahead of Data-
05 00 am
On track toward higher open
Wall Street headed for a moderately higher open Tuesday, regaining its upward momentum ahead of a fresh round of readings on the service sector, factory orders and pending home sales.
LUV] Southwest Airlines December load factor 69.7% vs. 68.2%
OREX
Orexigen Therapeutics, Inc. NASDAQ-GM
Huckman ticked off some names like Gilead Sciences (GILD) and Onyx Pharmaceuticals (ONXX).
Hickma said to look out for a company called Orexigen Therapeutics (OREX), which, he said, is coming out this week or next with the first data on late-stage results of a weight-loss drug.
http://www.marketwatch.com/
http://www.nasdaq.com/aspxcontent/NewsStory.aspx?cpath=20090105/fast_money_back_to_reality_29791.html&symbol=OREX&selected=OREX&selecteddisplaysymbol=OREX&coname=Orexigen%20Therapeutics,%20Inc.&logopath=%2flogos%2fOREX.GIF&market=NASDAQ-GM&pageName=Company%20News&mypage=companynews&title=%27Fast%20Money%27:%20Back%20to%20reality
Stock Futures Regain Momentum Ahead of Data-
05 00 am
On track toward higher open
Wall Street headed for a moderately higher open Tuesday, regaining its upward momentum ahead of a fresh round of readings on the service sector, factory orders and pending home sales.
LUV] Southwest Airlines December load factor 69.7% vs. 68.2%
OREX
Orexigen Therapeutics, Inc. NASDAQ-GM
Huckman ticked off some names like Gilead Sciences (GILD) and Onyx Pharmaceuticals (ONXX).
Hickma said to look out for a company called Orexigen Therapeutics (OREX), which, he said, is coming out this week or next with the first data on late-stage results of a weight-loss drug.
http://www.marketwatch.com/
http://www.nasdaq.com/aspxcontent/NewsStory.aspx?cpath=20090105/fast_money_back_to_reality_29791.html&symbol=OREX&selected=OREX&selecteddisplaysymbol=OREX&coname=Orexigen%20Therapeutics,%20Inc.&logopath=%2flogos%2fOREX.GIF&market=NASDAQ-GM&pageName=Company%20News&mypage=companynews&title=%27Fast%20Money%27:%20Back%20to%20reality
Comments